Author:
Xu Senyin,Huang Bin,Cao Youjun,Zhong Zhongyong,Yin Jiazhen
Abstract
Abstract
Background
Enterococcus casseliflavus is a rare pathogenic bacterium that is characterized by vancomycin resistance and can lead to multiple infections in the human body. This report describes a rare case of polycystic intrahepatic infection with E. casseliflavus which necessitated antibiotic treatment and surgical intervention involving cystic drainage.
Case Presentation
A 59-year-old woman, a long-term hemodialysis patient, was hospitalized due to a 5-day history of fever, abdominal pain, and diarrhea, which were possibly caused by the ingestion of contaminated food. Her blood culture yielded a positive result for E. casseliflavus, and she was initially treated with piperacillin/tazobactam and linezolid. Later, the antibiotic regimen was adjusted to include meropenem and linezolid. Despite treatment, her body temperature remained elevated. However, subsequent blood cultures were negative for E.casseliflavus.Conventional CT scans and ultrasound examinations did not identify the source of infection. However, a PET-CT examination indicated an intrahepatic cyst infection. Following MRI and ultrasound localization, percutaneous intrahepatic puncture and drainage were performed on the 20th day. Fluoroquinolones were administered for 48 days. On the 32nd day, MRI revealed a separation within the infected cyst, leading to a repeat percutaneous drainage at a different site. Subsequently, the patient’s temperature returned to normal. The infection was considered resolved, and she was discharged on the 62nd day. Follow-up results have been favorable thus far.
Conclusions
Based on the findings from this case, it is recommended to promptly conduct PET-CT examination to exclude the possibility of intracystic infection in cases of polycystic liver infection that are challenging to control. Furthermore, timely consideration should be given to puncture drainage in difficult cases.
Publisher
Springer Science and Business Media LLC
Reference28 articles.
1. Willey CJ, Blais JD, Hall AK, Krasa HB, Makin AJ, Czerwiec FS. Prevalence of autosomal dominant polycystic kidney disease in the European Union. Nephrol dialysis Transplantation: Official Publication Eur Dialysis Transpl Association’Eur Ren Association. 2017;32(8):1356–63.
2. Lanktree MB, Haghighi A, Guiard E, Iliuta IA, Song X, Harris PC, Paterson AD, Pei Y. Prevalence estimates of polycystic kidney and liver disease by Population sequencing. J Am Soc Nephrology: JASN. 2018;29(10):2593–600.
3. Savige J, Mallett A, Tunnicliffe DJ, Rangan GK. KHA-CARI autosomal Dominant polycystic kidney Disease Guideline: management of Polycystic Liver Disease. Semin Nephrol. 2015;35(6):618–622e615.
4. Gevers TJ, Drenth JP. Diagnosis and management of polycystic liver disease. Nat Reviews Gastroenterol Hepatol. 2013;10(2):101–8.
5. Suwabe T, Ubara Y, Sumida K, Hayami N, Hiramatsu R, Yamanouchi M, Hasegawa E, Hoshino J, Sawa N, Saitoh S, et al. Clinical features of cyst infection and hemorrhage in ADPKD: new diagnostic criteria. Clin Exp Nephrol. 2012;16(6):892–902.